Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar...

Area of Science:

• Cell biology
• Oncology
• Molecular signaling

Background:

• Decorin is known to inhibit tumor growth by affecting the epidermal growth factor receptor (EGFR).
• The precise mechanism by which decorin interacts with and modulates EGFR activity remains incompletely understood.

Purpose of the Study:

• To elucidate the molecular mechanism of decorin's interaction with the EGFR.
• To investigate the endocytic pathway utilized by decorin for EGFR internalization and degradation.

Main Methods:

• Direct binding assays to confirm decorin-EGFR interaction.
• Pharmacological disruption of clathrin-dependent and -independent endocytosis pathways.
• Confocal microscopy to track EGFR localization and trafficking.
• Biochemical assays to assess EGFR dimerization and degradation.

Main Results:

• Decorin directly binds to the EGFR, inducing its dimerization and subsequent internalization.
• Decorin-mediated EGFR internalization predominantly occurs via caveolar-mediated endocytosis.
• Unlike EGF, decorin-bound EGFR bypasses early and recycling endosomes, directly targeting late endosomes/lysosomes.
• Both decorin and EGF pathways converge for EGFR degradation in late endosomes/lysosomes.

Conclusions:

• Decorin employs a unique endocytic pathway involving caveolae for EGFR internalization.
• This novel mechanism of EGFR degradation by decorin provides a molecular basis for its anti-proliferative and anti-oncogenic properties.